Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 47

    1.

    [Food Security in Europe: comparison between the "Hygiene Package" and the British Retail Consortium (BRC) & International Food Standard (IFS) protocols]

    Stilo A, Parisi S, Delia S, Anastasi F, Bruno G, Laganà P.

    Ann Ig. 2009 Jul-Aug;21(4):387-401. Italian. PMID: 19798915 [PubMed - in process]Related articles

    2.

    Synthesis of some novel organic nitrates and comparative in vitro study of their vasodilator profile.

    Chegaev K, Lazzarato L, Marcarino P, Di Stilo A, Fruttero R, Vanthuyne N, Roussel C, Gasco A.

    J Med Chem. 2009 Jul 9;52(13):4020-5.PMID: 19438239 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of nitric oxide donor antioxidants containing the phenol vitamin E substructure and a furoxan moiety on ischemia/reperfusion injury.

    Di Stilo A, Chegaev K, Lazzarato L, Fruttero R, Gasco A, Rastaldo R, Cappello S.

    Arzneimittelforschung. 2009;59(3):111-6.PMID: 19402340 [PubMed - indexed for MEDLINE]Related articles

    4.

    Nitrooxymethyl-substituted analogues of celecoxib: synthesis and pharmacological characterization.

    Boschi D, Lazzarato L, Rolando B, Filieri A, Cena C, Di Stilo A, Fruttero R, Gasco A.

    Chem Biodivers. 2009 Mar;6(3):369-79.PMID: 19319873 [PubMed - indexed for MEDLINE]Related articles

    5.

    Studies of the potential genotoxic effects of furoxans: the case of CAS 1609 and of the water-soluble analogue of CHF 2363.

    Balbo S, Lazzarato L, Di Stilo A, Fruttero R, Lombaert N, Kirsch-Volders M.

    Toxicol Lett. 2008 Apr 21;178(1):44-51. Epub 2008 Feb 13.PMID: 18378101 [PubMed - indexed for MEDLINE]Related articles

    6.

    Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.

    Buonsanti MF, Bertinaria M, Stilo AD, Cena C, Fruttero R, Gasco A.

    J Med Chem. 2007 Oct 4;50(20):5003-11. Epub 2007 Sep 11.PMID: 17845020 [PubMed - indexed for MEDLINE]Related articles

    7.

    High-speed gas chromatography in doping control: fast-GC and fast-GC/MS determination of beta-adrenoceptor ligands and diuretics.

    Brunelli C, Bicchi C, Di Stilo A, Salomone A, Vincenti M.

    J Sep Sci. 2006 Dec;29(18):2765-71.PMID: 17305237 [PubMed - indexed for MEDLINE]Related articles

    8.

    The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.

    Del Grosso E, Boschi D, Lazzarato L, Cena C, Di Stilo A, Fruttero R, Moro S, Gasco A.

    Chem Biodivers. 2005 Jul;2(7):886-900.PMID: 17193179 [PubMed - indexed for MEDLINE]Related articles

    9.

    Amphiphilic NO-donor antioxidants.

    Chegaev K, Lazzarato L, Rolando B, Marini E, Lopez GV, Bertinaria M, Di Stilo A, Fruttero R, Gasco A.

    ChemMedChem. 2007 Feb;2(2):234-40.PMID: 17183594 [PubMed - indexed for MEDLINE]Related articles

    10.

    Fast gas chromatographic/mass spectrometric determination of diuretics and masking agents in human urine: Development and validation of a productive screening protocol for antidoping analysis.

    Morra V, Davit P, Capra P, Vincenti M, Di Stilo A, Botrè F.

    J Chromatogr A. 2006 Dec 1;1135(2):219-29. Epub 2006 Oct 5.PMID: 17027009 [PubMed - indexed for MEDLINE]Related articles

    11.

    NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties.

    Boschi D, Tron GC, Lazzarato L, Chegaev K, Cena C, Di Stilo A, Giorgis M, Bertinaria M, Fruttero R, Gasco A.

    J Med Chem. 2006 May 18;49(10):2886-97.PMID: 16686532 [PubMed - indexed for MEDLINE]Related articles

    12.

    Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomers.

    Chegaev K, Lazzarato L, Tron GC, Marabello D, Stilo AD, Cena C, Fruttero R, Gasco A, Vanthuyne N, Roussel C.

    Chirality. 2006 Jun;18(6):430-6.PMID: 16634127 [PubMed - indexed for MEDLINE]Related articles

    13.

    Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives.

    Tosco P, Bertinaria M, Di Stilo A, Cena C, Sorba G, Fruttero R, Gasco A.

    Bioorg Med Chem. 2005 Aug 1;13(15):4750-9.PMID: 15946850 [PubMed - indexed for MEDLINE]Related articles

    14.

    Non-imidazole histamine NO-donor H3-antagonists.

    Tosco P, Bertinaria M, Di Stilo A, Cena C, Fruttero R, Gasco A.

    Farmaco. 2005 Jun-Jul;60(6-7):507-12.PMID: 15927183 [PubMed - indexed for MEDLINE]Related articles

    15.

    Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants.

    Cena C, Boschi D, Tron GC, Chegaev K, Lazzarato L, Di Stilo A, Aragno M, Fruttero R, Gasco A.

    Bioorg Med Chem Lett. 2004 Dec 20;14(24):5971-4.PMID: 15546710 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients.

    Aragona P, Stilo A, Ferreri F, Mobrici M.

    Eye (Lond). 2005 May;19(5):535-9.PMID: 15184937 [PubMed - indexed for MEDLINE]Related articles

    17.

    Adult colocolic intussusception: demonstration by conventional MR techniques.

    Tamburrini S, Stilo A, Bertucci B, Barresi D.

    Abdom Imaging. 2004 Jan-Feb;29(1):42-4.PMID: 15160752 [PubMed - indexed for MEDLINE]Related articles

    18.

    A new class of NO-donor H3-antagonists.

    Tosco P, Bertinaria M, Di Stilo A, Marini E, Rolando B, Sorba G, Fruttero R, Gasco A.

    Farmaco. 2004 May;59(5):359-71.PMID: 15120315 [PubMed - indexed for MEDLINE]Related articles

    19.

    New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties.

    Visentin S, Rolando B, Di Stilo A, Fruttero R, Novara M, Carbone E, Roussel C, Vanthuyne N, Gasco A.

    J Med Chem. 2004 May 6;47(10):2688-93.PMID: 15115410 [PubMed - indexed for MEDLINE]Related articles

    20.

    Synthesis and vasodilating properties of N-alkylamide derivatives of 4-amino-3-furoxancarboxylic acid and related azo derivatives.

    Ovchinnikov IV, Kulikov AS, Makhova NN, Tosco P, Di Stilo A, Fruttero R, Gasco A.

    Farmaco. 2003 Sep;58(9):677-81.PMID: 13679160 [PubMed - indexed for MEDLINE]Related articles

    21.

    Accessory soleus muscle: US and MR findings.

    Stilo A, Tamburrini S, Santagada N, Console D.

    Radiol Med. 2003 Jul-Aug;106(1-2):126-9. English, Italian. No abstract available. PMID: 12951562 [PubMed - indexed for MEDLINE]Related articles

    22.

    New potential uroselective NO-donor alpha1-antagonists.

    Boschi D, Tron GC, Di Stilo A, Fruttero R, Gasco A, Poggesi E, Motta G, Leonardi A.

    J Med Chem. 2003 Aug 14;46(17):3762-5.PMID: 12904082 [PubMed - indexed for MEDLINE]Related articles

    23.

    [3-(1H-imidazol-4-yl)propyl]guanidines containing furoxan moieties: a new class of H3-antagonists endowed with NO-donor properties.

    Bertinaria M, Stilo AD, Tosco P, Sorba G, Poli E, Pozzoli C, Coruzzi G, Fruttero R, Gasco A.

    Bioorg Med Chem. 2003 Apr 3;11(7):1197-205.PMID: 12628647 [PubMed - indexed for MEDLINE]Related articles

    24.

    Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patients.

    Aragona P, Di Stefano G, Ferreri F, Spinella R, Stilo A.

    Br J Ophthalmol. 2002 Aug;86(8):879-84.PMID: 12140209 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Searching for balanced hybrid NO-donor 1,4-dihydropyridines with basic properties.

    Boschi D, Caron G, Visentin S, Di Stilo A, Rolando B, Fruttero R, Gasco A.

    Pharm Res. 2001 Jul;18(7):987-91.PMID: 11496959 [PubMed - indexed for MEDLINE]Related articles

    26.

    Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activities.

    Cena C, Visentin S, Di Stilo A, Boschi D, Fruttero R, Gasco A.

    Pharm Res. 2001 Feb;18(2):157-65.PMID: 11405285 [PubMed - indexed for MEDLINE]Related articles

    27.

    Ocular discomfort and conjunctival alterations in operating room workers. A single-institution pilot study.

    Fenga C, Aragona P, Cacciola A, Ferreri F, Spatari G, Stilo A, Spinella R, Germanò D.

    Int Arch Occup Environ Health. 2001 Mar;74(2):123-8.PMID: 11317705 [PubMed - indexed for MEDLINE]Related articles

    28.

    Anti-Helicobacter pylori agents endowed with H2-antagonist properties.

    Sorba G, Bertinaria M, Di Stilo A, Gasco A, Scaltrito MM, Brenciaglia MI, Dubini F.

    Bioorg Med Chem Lett. 2001 Feb 12;11(3):403-6.PMID: 11212121 [PubMed - indexed for MEDLINE]Related articles

    29.

    Nicorandil analogues containing NO-donor furoxans and related furazans.

    Boschi D, Cena C, Di Stilo A, Fruttero R, Gasco A.

    Bioorg Med Chem. 2000 Jul;8(7):1727-32.PMID: 10976520 [PubMed - indexed for MEDLINE]Related articles

    30.

    In vitro and in vivo vasodilating activity of nitroso derivatives gem -substituted with electron-withdrawing groups.

    Di Stilo A, Medana C, Ferrarotti B, Gasco AL, Ghigo D, Bosia A, Martorana PA, Gasco A.

    Pharmacol Res. 2000 Apr;41(4):469-74.PMID: 10704272 [PubMed - indexed for MEDLINE]Related articles

    31.

    NO donor and biological properties of different benzofuroxans.

    Medana C, Di Stilo A, Visentin S, Fruttero R, Gasco A, Ghigo D, Bosia A.

    Pharm Res. 1999 Jun;16(6):956-60.PMID: 10397620 [PubMed - indexed for MEDLINE]Related articles

    32.

    SAR studies on H2 antagonists containing alkylamino substituted 1,2, 5-thiadiazole 1-oxide moieties.

    Di Stilo A, Cena C, Lolli M, Sorba G, Gasco A, Bertaccini G, Pozzoli C, Adami M, Coruzzi G.

    Farmaco. 1998 Aug-Sep;53(8-9):536-40.PMID: 10081815 [PubMed - indexed for MEDLINE]Related articles

    33.

    New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.

    Di Stilo A, Visentin S, Cena C, Gasco AM, Ermondi G, Gasco A.

    J Med Chem. 1998 Dec 31;41(27):5393-401.PMID: 9876109 [PubMed - indexed for MEDLINE]Related articles

    34.

    Pyrazole analogues of prazosin.

    Ermondi G, Boschi D, Di Stilo A, Tironi C, Gasco A.

    Farmaco. 1998 Jul 30;53(7):519-24.PMID: 9836464 [PubMed - indexed for MEDLINE]Related articles

    35.

    Characterisation of furoxancarbonitriles as a new class of vasodilators.

    Gasco AM, Boschi D, Di Stilo A, Medana C, Gasco A, Martorana PA, Schönafinger K.

    Arzneimittelforschung. 1998 Mar;48(3):212-8.PMID: 9553676 [PubMed - indexed for MEDLINE]Related articles

    36.

    Studies on agents with mixed NO-dependent vasodilating and beta-blocking activities.

    Boschi D, Di Stilo A, Cena C, Lolli M, Fruttero R, Gasco A.

    Pharm Res. 1997 Dec;14(12):1750-8.PMID: 9453064 [PubMed - indexed for MEDLINE]Related articles

    37.

    Water soluble furoxan derivatives as NO prodrugs.

    Sorba G, Medana C, Fruttero R, Cena C, Di Stilo A, Galli U, Gasco A.

    J Med Chem. 1997 Feb 14;40(4):463-9. Erratum in: J Med Chem 1997 Jul 4;40(14):2288. PMID: 9046336 [PubMed - indexed for MEDLINE]Related articles

    38.

    The furoxan system as a useful tool for balancing "hybrids" with mixed alpha 1-antagonist and NO-like vasodilator activities.

    Fruttero R, Boschi D, Di Stilo A, Gasco A.

    J Med Chem. 1995 Dec 8;38(25):4944-9.PMID: 8523408 [PubMed - indexed for MEDLINE]Related articles

    39.

    The cyano-NNO-azoxy function in the design of an irreversible label for alpha 1 adrenoreceptors.

    Sorba G, Di Stilo A, Medana C, Cena C, Gasco A, Orsetti M.

    Bioorg Med Chem. 1995 Feb;3(2):173-8.PMID: 7796051 [PubMed - indexed for MEDLINE]Related articles

    40.

    Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation.

    Medana C, Ermondi G, Fruttero R, Di Stilo A, Ferretti C, Gasco A.

    J Med Chem. 1994 Dec 9;37(25):4412-6.PMID: 7996554 [PubMed - indexed for MEDLINE]Related articles

    41.

    Alpha 1-adrenoceptor blocking activity of some ring-open analogues of prazosin.

    Boschi D, Di Stilo A, Fruttero R, Medana C, Sorba G, Gasco A.

    Arch Pharm (Weinheim). 1994 Oct;327(10):661-7.PMID: 7826201 [PubMed - indexed for MEDLINE]Related articles

    42.

    Pharmacochemistry of the furoxan ring: recent developments.

    Calvino R, Di Stilo A, Fruttero R, Gasco AM, Sorba G, Gasco A.

    Farmaco. 1993 Feb;48(2):321-34. Erratum in: Farmaco 1993 Apr;48(4):321, 323-4, 333-4. PMID: 8388218 [PubMed - indexed for MEDLINE]Related articles

    43.

    Synthesis and H2-antagonist properties of some 1,2,5-thiadiazole-1-oxide derivatives.

    Sorba G, Di Stilo A, Gasco AM, Gili M, Gasco A, Orsetti M.

    Farmaco. 1992 Dec;47(12):1445-55.PMID: 1363461 [PubMed - indexed for MEDLINE]Related articles

    44.

    Potential histamine H2-receptor antagonists: synthesis and pharmacological activity of derivatives containing acylamino-furazan moieties.

    Sorba G, Fruttero R, Di Stilo A, Gasco A, Orsetti M.

    Arch Pharm (Weinheim). 1992 Mar;325(3):151-5.PMID: 1353669 [PubMed - indexed for MEDLINE]Related articles

    45.

    Furan and thiophene analogues of omeprazole.

    Sorba G, Di Stilo A, Gili M, Gasco A, Bertaccini G, Adami M, Coruzzi G.

    Acta Pharm Nord. 1992;4(4):195-200.PMID: 1294185 [PubMed - indexed for MEDLINE]Related articles

    46.

    Cytotoxic activity of a series of heteroaryl-ONN-azoxy-sulphones and aryl sulphonylhydrazones.

    Tironi C, Fruttero R, Di Stilo A, Aresca P, Bossa R, Galatulas I, Ninci M.

    Anticancer Res. 1989 May-Jun;9(3):609-10.PMID: 2764507 [PubMed - indexed for MEDLINE]Related articles

    47.

    In vitro cytotoxic activity of aryl and heteroaryl-ONN-azoxycyanides.

    Fruttero R, Calvino R, Di Stilo A, Gasco A, Galatulas I, Bossa R.

    Pharmazie. 1988 Jul;43(7):499-500.PMID: 3222284 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...